Cancer Research Insights & Advancements

Explore updates on our innovative clinical trials, advancements in cancer research, fundraising efforts and the latest developments in oncology.

For media inquiries: media@marycrowley.org

Sort By

MELANOMA

"Think about research for your advanced melanoma patient” - John Nemunaitis, MD

MARY CROWLEY QUARTERLY: VOLUME 3 ISSUE 3

VACCINE INSIGHTS FROM ONGOING TRIALS

Mary Crowley presented at the American Society of Clinical Oncology 2013 Annual Conference on May 31, 2013.

CLINICAL UPDATE OF BIFUNCTIONAL (BI)-SHRNAI NANOPLEX TECHNOLOGY IN CANCER

Mary Crowley presented at the American Society of Gene and Cellular Therapy 2013 Annual Conference this May.

CLINICAL UPDATE OF BI-SHRNA FURIN/GMCSF DNA TRANSFECTED TUMOR VACCINE: FANG IN CANCER PATIENTS

Mary Crowley presented at the American Society of Gene and Cellular Therapy 2013 Annual Conference this May.

MARY CROWLEY QUARTERLY: VOLUME 3 ISSUE 2

A FIRST IN HUMAN PHASE 1 STUDY OF CG0070, A GM-CSF EXPRESSING ONCOLYTIC ADENOVIRUS, FOR THE TREATMENT OF NONMUSCLE INVASIVE BLADDER CANCER

A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer.

MG98, A SECOND GENERATION DNMT1 INHIBITOR, IN THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA

MG98, A Second Generation DNMT1 Inhibitor, in the Treatment of Advanced Renal Cell Carcinoma.

FIRST-IN-MAN APPLICATION OF A NOVEL THERAPEUTIC CANCER VACCINE FORMULATION WITH THE CAPACITY TO INDUCE MULTI-FUNCTIONAL T CELL RESPONSES IN OVARIAN, BREAST AND PROSTATE CANCER PATIENTS

First-in-Man Application of a Novel Therapeutic Cancer Vaccine Formulation with the Capacity to Induce Multi-functional T Cell Responses in Ovarian, Breast and Prostate Cancer Patients.

Pages: 12345678910111213141516171819202122232425262728293031323334

Connect With Us

Whether you want to give a spark of hope or you are looking for it, we are here to help. If you have any questions or concerns, please contact us here.

7777 Forest Lane,
Building C-707
Dallas, TX 75230

972.566.3000

For media inquiries: media@marycrowley.org

Cancer Research Insights & Advancements

Subscribe to Our Newsletter

Connect With Us